REFERENCES
- Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995: 619–36.
- Bartlett JG, Breiman R, Mandell L, File TJr. Community-acquired pneumonia in adults: guidelines for man-agement. Clin Infect Dis 1998; 26: 811–38.
- Andes D, Craig WA. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother 1998; 42: 2375–9.
- Kaplan SL, Mason EOJr. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998; 11: 628–44.
- Woodnutt G, Berry V. Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 1999; 43: 29–34.
- Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respi-ratory tract infections. J Chemother 1997; 9 (suppl 3): 38-44.
- Fluckiger U, Moreillon P, Blaser J, Sickle M, Glauser MP, Francioli P. Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrob Agents Chemother 1994; 38: 2846–9.
- Calver A, Walsh N, Quinn P, Baran C, Lonergan V, Singh K, Orzolek W, the Lower Respiratory Tract Infection Collaborative Study Group. Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection. Clin Infect Dis 1997; 24: 570–4.
- Bantar C, Nicola F, Arenoso H et al. Pharmacokinetics and pharmacodynamics of amoxicillin-sulbactam, a novel aminopenicillin-β-lactamase inhibitor combination, against Escherichia coli. Antimicrob Agents Chemother 1999; 43: 1503–4.
- Craig WA. Pharmacokinetic/pharmacodynamic para-meter: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1997; 26: 1–12.
- Webb DC, Cripps AW. Immunization with recombinant transferrin binding protein B enhances clearance of nonty-peable Haemophilus influenzae from the rat lung. Infect Immun 1999; 67: 2138–44.